[5-[(1S,6R)-6-(acetyloxymethyl)-4,6-dimethyl-5-oxocyclohex-3-en-1-yl]-3-bromo-3-methylpentyl] acetate
C19H29BrO5 — CID 138980734
Data last refreshed: (MolForge compound catalog, from PubChem)
About [5-[(1S,6R)-6-(acetyloxymethyl)-4,6-dimethyl-5-oxocyclohex-3-en-1-yl]-3-bromo-3-methylpentyl] acetate
[5-[(1S,6R)-6-(acetyloxymethyl)-4,6-dimethyl-5-oxocyclohex-3-en-1-yl]-3-bromo-3-methylpentyl] acetate (PubChem CID 138980734) has the molecular formula C19H29BrO5 and a molecular weight of 417.34 g/mol. Its IUPAC name is [5-[(1S,6R)-6-(acetyloxymethyl)-4,6-dimethyl-5-oxocyclohex-3-en-1-yl]-3-bromo-3-methylpentyl] acetate.
Molecular Properties
| Compound Name | [5-[(1S,6R)-6-(acetyloxymethyl)-4,6-dimethyl-5-oxocyclohex-3-en-1-yl]-3-bromo-3-methylpentyl] acetate |
|---|---|
| PubChem CID | 138980734 |
| Molecular Formula | C19H29BrO5 |
| Molecular Weight | 417.34 g/mol |
| Exact Mass | 416.12 |
| IUPAC Name | [5-[(1S,6R)-6-(acetyloxymethyl)-4,6-dimethyl-5-oxocyclohex-3-en-1-yl]-3-bromo-3-methylpentyl] acetate |
| SMILES | CC(=O)OCCC(C)(Br)CC[C@H]1CC=C(C)C(=O)[C@@]1(C)COC(C)=O |
| InChI | InChI=1S/C19H29BrO5/c1-13-6-7-16(19(5,17(13)23)12-25-15(3)22)8-9-18(4,20)10-11-24-14(2)21/h6,16H,7-12H2,1-5H3/t16-,18?,19+/m1/s1 |
| InChIKey | VOHHNLMPQLQERA-WDOSNPKHSA-N |
| XLogP | 3.98 |
| TPSA | 69.67 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 417.34 |
| LogP ≤ 5 | 3.98 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'alkyl_halide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138980734 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.